Global prevalence of chronic migraine: A systematic review

J. L. Natoli, A. Manack, B. Dean, Q. Butler, C. C. Turkel, L. Stovner, Richard B. Lipton

Research output: Contribution to journalArticle

313 Citations (Scopus)

Abstract

The aim of this review was to summarize population-based studies reporting prevalence and/or incidence of chronic migraine (CM) and to explore variation across studies. A systematic literature search was conducted. Relevant data were abstracted and estimates were subdivided based on the criteria used in each study. Sixteen publications representing 12 studies were accepted. None presented data on CM incidence. The prevalence of CM was 0-5.1%, with estimates typically in the range of 1.4-2.2%. Seven studies used Silberstein-Lipton criteria (or equivalent), with prevalence ranging from 0.9% to 5.1%. Three estimates used migraine that occurred ≥ 15 days per month, with prevalence ranging from 0 to 0.7%. Prevalence varied by World Health Organization region and gender. This review identified population-based studies of CM prevalence, although heterogeneity across studies and lack of data from certain regions leaves an incomplete picture. Future studies on CM would benefit from an International Classification of Headache Disorders consensus diagnosis that is clinically appropriate and operational in epidemiological studies.

Original languageEnglish (US)
Pages (from-to)599-609
Number of pages11
JournalCephalalgia
Volume30
Issue number5
DOIs
StatePublished - May 2010

Fingerprint

Migraine Disorders
Headache Disorders
Population
Publications
Epidemiologic Studies
Cohort Studies
Cross-Sectional Studies
Incidence

Keywords

  • Chronic migraine
  • Epidemiology
  • Prevalence
  • Systematic review

ASJC Scopus subject areas

  • Clinical Neurology

Cite this

Natoli, J. L., Manack, A., Dean, B., Butler, Q., Turkel, C. C., Stovner, L., & Lipton, R. B. (2010). Global prevalence of chronic migraine: A systematic review. Cephalalgia, 30(5), 599-609. https://doi.org/10.1111/j.1468-2982.2009.01941.x

Global prevalence of chronic migraine : A systematic review. / Natoli, J. L.; Manack, A.; Dean, B.; Butler, Q.; Turkel, C. C.; Stovner, L.; Lipton, Richard B.

In: Cephalalgia, Vol. 30, No. 5, 05.2010, p. 599-609.

Research output: Contribution to journalArticle

Natoli, JL, Manack, A, Dean, B, Butler, Q, Turkel, CC, Stovner, L & Lipton, RB 2010, 'Global prevalence of chronic migraine: A systematic review', Cephalalgia, vol. 30, no. 5, pp. 599-609. https://doi.org/10.1111/j.1468-2982.2009.01941.x
Natoli JL, Manack A, Dean B, Butler Q, Turkel CC, Stovner L et al. Global prevalence of chronic migraine: A systematic review. Cephalalgia. 2010 May;30(5):599-609. https://doi.org/10.1111/j.1468-2982.2009.01941.x
Natoli, J. L. ; Manack, A. ; Dean, B. ; Butler, Q. ; Turkel, C. C. ; Stovner, L. ; Lipton, Richard B. / Global prevalence of chronic migraine : A systematic review. In: Cephalalgia. 2010 ; Vol. 30, No. 5. pp. 599-609.
@article{168286548edd4a3fa1f224912db4de55,
title = "Global prevalence of chronic migraine: A systematic review",
abstract = "The aim of this review was to summarize population-based studies reporting prevalence and/or incidence of chronic migraine (CM) and to explore variation across studies. A systematic literature search was conducted. Relevant data were abstracted and estimates were subdivided based on the criteria used in each study. Sixteen publications representing 12 studies were accepted. None presented data on CM incidence. The prevalence of CM was 0-5.1{\%}, with estimates typically in the range of 1.4-2.2{\%}. Seven studies used Silberstein-Lipton criteria (or equivalent), with prevalence ranging from 0.9{\%} to 5.1{\%}. Three estimates used migraine that occurred ≥ 15 days per month, with prevalence ranging from 0 to 0.7{\%}. Prevalence varied by World Health Organization region and gender. This review identified population-based studies of CM prevalence, although heterogeneity across studies and lack of data from certain regions leaves an incomplete picture. Future studies on CM would benefit from an International Classification of Headache Disorders consensus diagnosis that is clinically appropriate and operational in epidemiological studies.",
keywords = "Chronic migraine, Epidemiology, Prevalence, Systematic review",
author = "Natoli, {J. L.} and A. Manack and B. Dean and Q. Butler and Turkel, {C. C.} and L. Stovner and Lipton, {Richard B.}",
year = "2010",
month = "5",
doi = "10.1111/j.1468-2982.2009.01941.x",
language = "English (US)",
volume = "30",
pages = "599--609",
journal = "Cephalalgia",
issn = "0333-1024",
publisher = "SAGE Publications Ltd",
number = "5",

}

TY - JOUR

T1 - Global prevalence of chronic migraine

T2 - A systematic review

AU - Natoli, J. L.

AU - Manack, A.

AU - Dean, B.

AU - Butler, Q.

AU - Turkel, C. C.

AU - Stovner, L.

AU - Lipton, Richard B.

PY - 2010/5

Y1 - 2010/5

N2 - The aim of this review was to summarize population-based studies reporting prevalence and/or incidence of chronic migraine (CM) and to explore variation across studies. A systematic literature search was conducted. Relevant data were abstracted and estimates were subdivided based on the criteria used in each study. Sixteen publications representing 12 studies were accepted. None presented data on CM incidence. The prevalence of CM was 0-5.1%, with estimates typically in the range of 1.4-2.2%. Seven studies used Silberstein-Lipton criteria (or equivalent), with prevalence ranging from 0.9% to 5.1%. Three estimates used migraine that occurred ≥ 15 days per month, with prevalence ranging from 0 to 0.7%. Prevalence varied by World Health Organization region and gender. This review identified population-based studies of CM prevalence, although heterogeneity across studies and lack of data from certain regions leaves an incomplete picture. Future studies on CM would benefit from an International Classification of Headache Disorders consensus diagnosis that is clinically appropriate and operational in epidemiological studies.

AB - The aim of this review was to summarize population-based studies reporting prevalence and/or incidence of chronic migraine (CM) and to explore variation across studies. A systematic literature search was conducted. Relevant data were abstracted and estimates were subdivided based on the criteria used in each study. Sixteen publications representing 12 studies were accepted. None presented data on CM incidence. The prevalence of CM was 0-5.1%, with estimates typically in the range of 1.4-2.2%. Seven studies used Silberstein-Lipton criteria (or equivalent), with prevalence ranging from 0.9% to 5.1%. Three estimates used migraine that occurred ≥ 15 days per month, with prevalence ranging from 0 to 0.7%. Prevalence varied by World Health Organization region and gender. This review identified population-based studies of CM prevalence, although heterogeneity across studies and lack of data from certain regions leaves an incomplete picture. Future studies on CM would benefit from an International Classification of Headache Disorders consensus diagnosis that is clinically appropriate and operational in epidemiological studies.

KW - Chronic migraine

KW - Epidemiology

KW - Prevalence

KW - Systematic review

UR - http://www.scopus.com/inward/record.url?scp=77954762392&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77954762392&partnerID=8YFLogxK

U2 - 10.1111/j.1468-2982.2009.01941.x

DO - 10.1111/j.1468-2982.2009.01941.x

M3 - Article

C2 - 19614702

AN - SCOPUS:77954762392

VL - 30

SP - 599

EP - 609

JO - Cephalalgia

JF - Cephalalgia

SN - 0333-1024

IS - 5

ER -